Abstract Phyllodes tumour or cystosarcoma phyllodes is a rare stromal breast tumour that is usually benign but on rare occasions can turn malignant. Non-specificity of the imaging features on sonography and mammography makes it difficult to distinguish malignant from benign counterparts solely based on imaging. The final diagnosis is still highly dependent on histopathological assessment. Herein, we describe two cases of malignant phyllodes tumour with emphasis on magnetic resonance (MR) imaging features using advanced MR applications.
Introduction
Phyllodes tumours are uncommon fibroepithelial tumours, which are classified into benign, borderline malignant, or malignant based on their histopathological criteria [1] . Stromal cellularity, cellular pleomorphism and mitotic rate, margin morphology, and stromal overgrowth are assessed in determining malignancy. Malignant phyllodes tumours tend to have high stromal cellularity, stromal cell pleomorphism, high mitotic count, an infiltrative margin, and stromal overgrowth, while benign tumours tend to show the reverse [1] . Herein, we present two cases of malignant phyllodes tumour with particular highlight on advanced MR imaging findings and the possibility of differentiation between benign and malignant lesions.
Case report

Case 1
A 32-year-old lactating woman presented to us with progressive right breast swelling associated with fever, cyclical pain and tenderness as well as serous nipple discharge over a period of 6 months. There was rapid enlargement of her right breast with increasing pain in the week prior to presentation.
She was febrile with temperature of 38.4°C and tachycardic with pulse rate of 101 beats per minute. Physical examination revealed a grossly swollen right breast with fluctuant areas. Aspiration of a fluctuant area revealed thick mucoid fluid. She was diagnosed with breast abscess and was admitted to the surgical ward for intravenous antibiotics. She was examined in the ward by a breast surgeon who considered a differential diagnosis of phyllodes tumour and performed direct core biopsies of two separate areas in the right breast.
Breast ultrasound showed a large, irregular, heterogeneous, complex solid mass with cystic components and increased internal vascularity. There was distortion and effacement of the surrounding right breast parenchyma. The left breast was normal.
Mammogram was not done because of difficulty in compressing the painful and enlarged breast. Diagnostic MR imaging was performed using the General Electric Signa HDx 3.0-T MR scanner (manufacturer: GE Medical Systems, Waukesha, WI, USA) using a double breast coil with the patient in a prone position. Prior to contrast administration, axial fat-suppressed T2W/axial T2W STIR and axial fat-suppressed T1W (field of view 40 9 40 cm, matrix 416 9 256; slice thickness 4 mm; receiver bandwidth of 83.3 kHz per pixel; total time of acquisition 5 min 41 s) images were obtained. Axial diffusion-weighted images with spin echo-planar imaging were made with the following parameters: for a b value of 500 s/mm 2 [TR 8000/TE 70.9; field of view 40 9 40 cm, matrix 80 9 128; receiver bandwidth 250 kHz per pixel; time of acquisition 2 min 24 s; number of excitations (NEX) 4]; for a b value of 1000 s/mm 2 (TR 8000/TE 80.9; field of view 40 9 40 cm, matrix 80 9 128; receiver bandwidth 250 kHz per pixel; time of acquisition 2 min 24 s; NEX 4). A bolus of intravenous contrast medium (gadopentetate dimeglumine) was administered at a dose of 0.2 mmol/kg body weight (Magnevist 0.5 mmol/ml), followed by 10 ml of saline solution (1.0 %). Dynamic MRI (VIBRANT) with and without fat suppression was performed before and 6 times after injection of contrast. The parameters for dynamic MRI were as follows: TR 4.3/TE 2.1, flip angle 10°, field of view 36 9 36 cm, matrix 256 9 256, receiver bandwidth 62.50 kHz per pixel; slice thickness 1.6 mm; time of acquisition 5 min 30 s (46 s per dynamic sequence, 1 mask image and dynamic images obtained every minute for 6 min). Post-processing multiplanar reconstruction in sagittal and coronal planes and apparent diffusion coefficient images for b values of 500 and 1000 s/mm 2 were obtained. The spectroscopic volume of interest (VOI) was positioned within the lesion and was adjusted with the VOI size measuring 1 cm 9 1 cm 9 1 cm. Point-resolved spectroscopy sequence (PRESS) was performed (TR/TE 2000 ms/270 ms) of 256 9 256 matrix, and single shot unsuppressed spectrum was performed in the VOI. Total time of performing and planning of the spectroscopic sequence was 2-5 min. Control spectra were positioned in the healthy-appearing glandular tissue. Spectra of normal breast tissue were presumed to not have a peak at 3.2 ppm. MRI showed a large heterogeneously enhancing mass with lobulated margins measuring 15.8 9 15.2 9 11.4 cm occupying the right breast with complex solid and cystic areas. This mass showed heterogeneously higher signal intensity than normal breast tissue on T2W images and heterogeneously high or equal signal intensity to normal breast tissue on T1W images (Fig. 1a-d ). There was also evidence of infiltration into the underlying pectoralis muscle.
Dynamic contrast-enhanced MRI (DCE-MRI) showed rapid early contrast uptake and a washout kinetic curve (type III curve), which is typical of malignant enhancement (Fig. 2a) . The DCE-MR images were sequentially obtained before and 6 phases after the administration of a 10-ml bolus of intravenous gadopentetate dimeglumine at 0, 60, 120, 180, 240, 300, and 360 s. Single-voxel proton spectroscopy showed a discrete peak from baseline at 3.2 parts per million (ppm), indicating detectable choline (Fig. 2b-c) . The mass displayed increased signal intensity on diffusion-weighted images (DWI) with a reduced apparent diffusion coefficient value (ADC) of 1.03 9 10 -3 mm 2 /s at a b value of 1000 mm 2 /s (Fig. 2d) . As the core biopsy results included the differential diagnoses of stromal components of a malignant phyllodes tumour and a sarcoma with chondroid differentiation metaplastic breast carcinoma, excision biopsy was recommended. The biopsies, which were 2 cores of tissue each measuring about 0.8 and 1.0 cm in length, revealed proliferation of malignant spindle-shaped cells that were pleomorphic and had a high proliferative index as seen by the increased mitosis and Ki67 proliferative index of more than 60 %, surrounded by a chondromyxoid stroma and presence of some osteoclastic multinucleated giant cells. There were no malignant epithelial components or benign breast ducts seen. Based on the biopsy findings, the presence of only the sarcomatous component without the epithelial component suggested a sarcoma with underlying chondroid differentiation, but the possibility of a metaplastic carcinoma or sarcomatous components of a malignant phyllodes tumour needed to be excluded. However, right mastectomy and axillary clearance was performed in view of the possibility of malignancy on histopathology examination, extensive tumour growth, and based on the patient's request. On gross appearance, the tumour measured 23.0 9 16.0 9 11.0 cm. Histological specimen showed a circumscribed, non-capsulated nodular tumour composed of moderately differentiated, spindle-shaped cells arranged in a herringbone pattern within an extensive myxoid stroma. There were focal areas that were more cellular and pleomorphic showing a higher mitotic rate of [20/10 HPF. The malignant cells diffusely reacted to actin and CD10 with a Ki67 proliferative index of around 50 %. There was a nodule that showed muscle invasion with lymphocytic infiltrates, which was positive for vimentin. The final histopathology confirmed the diagnosis of malignant phyllodes tumour with muscle invasion and negative axillary lymph node involvement. The patient recovered well after the surgery and was referred to the oncology team for further management. A 57-year-old woman presented with a 2-month history of enlarging painless right breast mass. a Axial T2W with fat saturation showed a heterogeneous, predominantly high signal intensity complex cystic and solid mass at the right retroareolar region; there is a small area of low signal intensity within (black arrow). b Axial T1W with fat saturation showed predominantly heterogeneously high and equal signal intensity to a glandular tissue mass at the retro-areolar region (black arrow). c Sagittal T1W postgadolinium MIP (maximal intensity projection) showed significant enhancement (black arrow). d Sagittal post-gadolinium with fat saturation, showing a well-defined heterogeneously enhancing mass in the right breast. There were hypointense areas in the center of the mass consistent with a necrotic center (white arrow). There was no axillary lymphadenopathy (color figure online) Case 2 A 57-year-old woman presented with a 2-month history of an enlarging painless right breast mass. There was no nipple discharge, nipple retraction, or axillary lymphadenopathy. Mammogram was performed, and comparison with the previous mammogram 1 year earlier revealed a new well-defined mass at the right lower quadrants with scattered macrocalcifications.
MRI (GE Healthcare Signa Ò HDx MR 3 T) with a similar technique was used and showed a well-defined, rimenhancing mass at the right lower quadrants measuring 3.6 9 3.7 cm. This mass showed heterogenous and predominantly high signal intensity on T2W images and on T1W images. There is a small area of low signal intensity seen on T2W images. This complex heterogeneous mass consisted of mixed solid and cystic components with several non-enhancing septae within (Fig. 3a-d) . DWI showed restricted diffusion with the ADC value of 1.45 9 10 -3 mm 2 /s at b value of 1000 mm 2 /s. (Fig. 4d) . The DCE-MRI at 60-s interval post-contrast injection showed rapid uptake and a washout pattern of enhancement, which was consistent with a type III curve (Fig. 4a) . Single-voxel proton spectroscopy showed a significant choline peak at 3.2 ppm (Fig. 4c) . The same region of interest (ROI) was selected for DCE-MR, spectroscopy and the ADC value, which was based on the most enhancing solid component of the lesion on the T1W post-gadolinium images.
Fine-needle aspiration cytology (FNAC) showed spindle cell tumour with the possibility of malignant phyllodes tumour, following which a wide local excision was performed. The histopathological examination showed a hypercellular breast tumour composed of malignant pleomorphic spindle cells with high mitotic activity and aberrant mitoses. Heterologous differentiation was not present. Pericanalicular patterned ducts lined by columnar epithelial cells were seen very focally and formed an integral part of the tumour. Tumour cells were seen at two of the surgical margins. The stromal cells were vimentin positive, and the ductal epithelial cells were MNF-116 and EMA positive. These findings were compatible with malignant phyllodes tumour. In view of the incomplete margins of tumour resection, simple mastectomy with axillary dissection was performed. Annual surveillance mammogram and ultrasound over 2 years revealed no evidence of tumour recurrence.
Discussion
Phyllodes tumour of the breast is a rare disorder usually affecting women between 40 and 50 years old, and it typically presents with a rapidly enlarging breast mass [2] .
The ultrasound (US) and clinical findings of our patients were consistent with previously reported cases [2] . The first patient showed a huge mass, which grew rapidly in size. Ultrasound showed a highly vascularised complex cystic and solid mass with frond-like papillary projections. Cheong et al. [2] outlined a few characteristics that favour the diagnosis of phyllodes tumour, i.e., a large mass with rapidly increasing size, increased vascularity on colour Doppler, and a cleft-like and rounded cystic space on ultrasonogram.
The patient in our first case initially presented with typical signs and symptoms of a breast abscess. Ultrasound showed a complex mass with mixed solid and cystic components. The ADC and DWI mapping image correlations were also suggestive of a breast abscess. However, in view of its rapid increase in size as well as MR morphology, DCE findings, and spectroscopy, the differential diagnosis of a malignant tumour was considered, i.e., malignant phyllodes tumour or inflammatory breast carcinoma.
Wurdinger et al. [3] described no significant differentiation between malignant and benign phyllodes tumour using MRI morphology alone. However, several studies describe characteristics of phyllodes tumour on MRI with histopathological correlation in determining MR characteristics of a benign tumour against those with malignant changes [4, 5] . Our study showed similar findings to Yabuuchi et al. [4] , showing that cystic changes with an irregular wall on ultrasound were suggestive of malignant rather than benign phyllodes tumour. Areas of high signal intensities on T1W that are suggestive of haemorrhagic changes, as demonstrated in both of our patients, were also consistent with that previous study [4] .
The MR findings that were statistically significant in favour of a malignancy include low ADC value, a cystic lesion with a thick irregular wall, and areas of lower intensity to breast tissue on T2W [4] . Low signal intensity areas on T2W and a low ADC value on DWI sequences were indicative of interstitial hypercellularity [4] . Our two cases showed lobulated masses with heterogenous internal intensity and non-enhancing septae, which can be observed in both benign phyllodes tumour and fibroadenoma. However, mixed cystic and solid components with areas of low signal intensity on T2W, which indicate malignancy, were also demonstrated in both our cases (Figs. 1a-d, 4a-d) .
The tumours in our cases displayed rapid early contrast uptake with a dynamic washout pattern (type III curve) on the kinetic curve analysis. This pattern of dynamic enhancement is typically observed in invasive breast carcinomas. Yabuuchi et al. [4] observed that the contrastenhanced dynamic study demonstrated a variable pattern of the time-signal intensity curve rendering it statistically non-significant as a feature of malignancy in phyllodes tumours. The ADC values of 1.45 and 1.03 9 10 -3 mm 2 /s that were calculated for our patients were comparable to the published data, which showed 1.37 ± 0.03 9 10 -3 mm 2 /s [4] . In contradiction, the benign counterparts were shown to reveal an ADC value of 1.87 ± 0.11 9 10 -3 mm 2 /s. ADC values also seemed to be lower in invasive rather than in in situ tumours. These results led to the hypothesis that ADC values might have a correlation with tumour grading and cellularity [4] .
Detectable choline in MR spectroscopy in malignant breast lesions has been well documented in the published literature. In cases of phyllodes tumour, a study by Guerrero et al. [6] failed to show the differentiation between benign and intermediate types by using MR spectroscopy. Another study by Tse et al. [1] on MR spectroscopy also reported the absence of a choline peak in six phyllodes tumours. Our case studies, however, revealed detectable choline metabolites on MR spectroscopy (Fig. 3b) . It is postulated that high proliferative activity in malignant phyllodes might be the reason for detectable choline.
Phyllodes tumour requires surgical resection for the final diagnosis as a small percentage may be malignant and thus can only be confirmed by histopathological examination [7] . The definitive treatment for malignant phyllodes tumour is wide excision of the tumour with clear adequate margins or mastectomy depending on the size of tumour and the patients' breast size [8] . Survival rates for malignant phyllodes tumour were 82 and 42 % at 5 and 10 years, respectively, as reported by Chaney et al. [8] . Benign phyllodes tumours, however, rarely metastasise, while their malignant counterparts metastasise in 25 % of cases and most frequently affect the lungs, pleura, and bones [6] . 
Conclusion
Our studies have shown that MR morphology assessment alone was not adequate in differentiating malignant from benign phyllodes tumour. The advanced MR techniques of dynamic contrast-enhanced spectroscopy and the ADC value in combination with morphology are useful tools to differentiate between malignant and benign phyllodes tumours.
